Business Overview:
HemoGenix, Inc. was founded in 2000 and continues to be a key player in stem cell assay market. The company has developed superior proprietary testing procedures for toxicology testing which have been used by top biopharmaceutical companies for new drug candidates. Many of the tests sold worldwide have been further developed for in-house testing for stem cell and veterinary research, cellular therapy, and regenerative medicine. In 2017, Preferred Cell Systems, Inc. (PCS) was formed and the new website www.preferred-cell-systems.com was launched to help further educate, productize, and market these advanced testing kits and assays. HemoGenix currently has a research contract related to COVID-19 for toxicity testing which is required by the FDA for any new drug. Subject to additional approvals the contract could be significantly larger. With the renewed global emphasis on reliable testing platforms, HemoGenix and Preferred Cell Systems are ready for new ownership to leverage long established industry relationships for contract services and further scale the distribution of its many developed kits and assays. The current owner has built an experienced, well-trained team in place to fulfill all orders and only works to help procure new business. He is looking to retire but would like to consult for a negotiated timeframe to help in the successful transition of the intellectual property and all in-house lab procedures.
Although the owner has approved the disclosure of the business names, all inquiries should be directed to The FBB Group.
To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button and when you are done searching and have made all your selections, simply click on the REQUEST INFO button at the bottom of the page.
Reason for Selling:
Retirement
Additional Details:
- The property is leased.
- The owner is willing to train/assist the new owner.
- This is not a homebased business opportunity.
- This is not a franchise resale opportunity.
Relevant Links: